Dr. Lonial Discusses Ongoing Research With BiTEs and CAR T-Cell Therapy in Myeloma

Sagar Lonial, MD, FACP, discusses the development of bispecific T-cell engagers (BiTEs) and CAR T-cell therapy in multiple myeloma.

Sagar Lonial, MD, FACP, professor and chair in the Department of Hematology and Medical Oncology of Emory University School of Medicine and chief medical officer of Winship Cancer Institute of Emory University, discusses the development of bispecific T-cell engagers (BiTEs) and CAR T-cell therapy in multiple myeloma.

Related Content:

Winship Cancer Institute of Emory UniversityOncLive TVMultiple Myeloma
Dr Weiss on the Role of Breast Imaging in Breast Cancer Treatment Decision-Making
Dr Herbst on the Evolution of EGFR Inhibition in Lung Cancer
Belantamab Mafodotin Plus Bortezomib/Dexamethasone Extends OS in R/R Myeloma